Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Smilow Cancer Hospital-Derby Care Center
Derby, Connecticut, United States
- Smilow Cancer Hospital Care Center-Fairfield
Fairfield, Connecticut, United States
- Smilow Cancer Hospital Care Center - Guilford
Guilford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Smilow Cancer Hospital-Orange Care Center
Orange, Connecticut, United States
- Smilow Cancer Hospital-Torrington Care Center
Torrington, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
- Smilow Cancer Hospital-Waterbury Care Center
Waterbury, Connecticut, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Moffitt Cancer Center-International Plaza
Tampa, Florida, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
- University of Kansas Clinical Research Center
Fairway, Kansas, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Weisberg Cancer Treatment Center
Farmington Hills, Michigan, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Medicine-Bellevue
Bellevue, Nebraska, United States
- Nebraska Medicine-Village Pointe
Omaha, Nebraska, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Mar 2017
- Primary completion
- 31 Aug 2026
- Completion
- 31 Aug 2026
- Last update posted
- 22 May 2026
- Registered enrollment
- 81
- Registry id
- NCT02849496
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.